ARTES successfully completed EU funded poject Plurivax
Under the titel: “ERA-Net EuroTransBio-8: PLURIVAX, development of a virus-like-particle (VLP) based vaccine platform an…
Under the titel: “ERA-Net EuroTransBio-8: PLURIVAX, development of a virus-like-particle (VLP) based vaccine platform an…
ARTES Biotechnology specialized in microbial process development and technology transfer for pharmaceutical industry is…
B3C newswire / -[/b] ARTES Biotechnology, InstrAction and Q-Biologicals establish a three-party consortium for vaccine d…